Clinical Trial 4690

Bryan, TX 77802


Summary:

We are currently conducting a multi-center, randomized, double-blind study to evaluate the efficacy and long-term safety of vildagliptin modified release (MR) as monotherapy in patients with type 2 diabetes.


Qualified Participants Must:

• Be 18 years of age or older
• Have untreated type 2 diabetes


Qualified Participants May Receive:

Up to $1,000 paid to qualified participants.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.